| Title |
Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
|
|---|---|
| Published in |
PLOS ONE, May 2013
|
| DOI | 10.1371/journal.pone.0063057 |
| Pubmed ID | |
| Authors |
Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C. Victor, Paul van Helden, Martin Groubusch, Robin Warren, Motasim Badri, Keertan Dheda |
| Abstract |
Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patients with XDR-TB are scarce. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 2 | 1% |
| Malaysia | 1 | <1% |
| Unknown | 171 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 39 | 22% |
| Researcher | 27 | 16% |
| Student > Bachelor | 18 | 10% |
| Student > Ph. D. Student | 17 | 10% |
| Student > Postgraduate | 13 | 7% |
| Other | 26 | 15% |
| Unknown | 34 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 72 | 41% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 6% |
| Agricultural and Biological Sciences | 10 | 6% |
| Nursing and Health Professions | 9 | 5% |
| Immunology and Microbiology | 7 | 4% |
| Other | 20 | 11% |
| Unknown | 45 | 26% |